Navigation Links
Jharkhand Chemists to Boycott Viagra

Chemists in Jharkhand are refusing to stock the sexual elixir Viagra saying that it would lead people to "berserk and create law and order problems." Viagra hit Indian shores// seven years after it created waves worldwide for the treatment of erectile dysfunction (ED).

"We will not sale the drug as it may lead to some people going berserk and creating law and order problems," said Amar Sinha, general secretary of the Jharkhand Chemist and Druggist Association (JCDA). The manufacturer of Viagra, which is chemically sildenafil citrate, is launching the product in India next week. Sinha says that they have requested Pfizer not to bring Viagra to Jharkand. "We have informed Pfizer not to launch the drug in Jharkhand. If our request is heeded, we will boycott the drug," said Sinha. A medical shop owner also echoed the comments voiced by Sinha, “The common practice here is to sell medicines even without a prescription. But Viagra is supposed to be sold strictly on prescription. We fear many customers will demand Viagra without producing a prescription and that may create law and order problems." Sinha said that if Viagra made it to the state then the drug dealers would make a neat profit, but that did not mean that they were prepared to risk the lives of other people since the youth in the state were already high on cough syrups.
'"/>




Page: 1

Related medicine news :

1. Jharkhand reports 13,000 Malaria cases
2. Jharkhand To Have Mobile Hospital
3. Jharkhand Gives Health industry status
4. Jharkhand Pharmacies Refuse To Sell Viagra
5. Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt
6. Ramdev Signs MOU With Jharkhand Govt To Set Up Ayurveda Hospital
7. Jharkhand Govt Tie Up With Ramdev To Preserve Rare Herbal Plants
8. Jharkhand To Host Chicken Festival
9. Jharkhand Faces Acute Shortage Of Life-saving Drugs
10. Druggists On Strike In Jharkhand To Protest Against VAT Anomalies
11. Jharkhand Druggists Call Off Strike
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... 2017 , ... Studies show evidence that carotenoids and antioxidants derived either from ... these patients. , But how often do ophthalmologists and optometrists in Sweden recommend the ... of or with early symptoms of AMD? A study published recently in ...
(Date:6/23/2017)... ... 2017 , ... Everybody has their own personal preference when it comes to ... some people don't like it at all. FindaTopDoc took a look at what makes ... can give readers a taste of their deepest, darkest fantasies and has the ability ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University will ... 20. , The two-day conference is focused on advancing scientific knowledge about the ... lives and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating Actionable ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance ... With the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more ... 2012, the Biggert-Waters Act was enacted to reflect the actual risk in flood ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... planning services to communities in the greater Chicago metropolitan area, is embarking on ... to underprivileged youth in Chicago. , Founded in 1897, Hephzibah Children’s Association is ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: